These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2026669)

  • 1. Comparison of methods for the prediction of phenytoin concentrations.
    Vázquez Rodríguez A; Santos Buelga D; Alonso González AC; Garcćia Sánchez MJ; Domínguez-Gil Hurlé A
    J Clin Pharm Ther; 1991 Feb; 16(1):55-62. PubMed ID: 2026669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of single-point phenytoin dosage prediction techniques.
    Yukawa E; Higuchi S; Ohtsubo K; Aoyama T
    J Clin Pharm Ther; 1988 Aug; 13(4):293-305. PubMed ID: 3235480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic approach to a dosage regimen for phenytoin based on one-point, steady-state plasma concentration.
    Nakashima E; Matsushita R; Kido H; Nakamura M; Asahi M; Ichimura F
    Ther Drug Monit; 1995 Feb; 17(1):12-8. PubMed ID: 7725371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of single-point phenytoin dosage prediction methods in pediatric patients.
    Yukawa E; Higuchi S; Aoyama T
    J Pharmacobiodyn; 1988 Nov; 11(11):736-43. PubMed ID: 3236206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of population pharmacokinetic parameters in phenytoin dosage adjustment.
    Yukawa E; Higuchi S; Aoyama T
    Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3363-6. PubMed ID: 2632085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new approach to establishing individualized maintenance doses of phenytoin.
    Bachmann K; Sullivan TJ; Schwartz J; Jauregui L
    Ther Drug Monit; 1985; 7(4):391-400. PubMed ID: 4082238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian regression analysis of non-steady-state phenytoin concentrations: evaluation of predictive performance.
    Killilea T; Coleman R; Ludden T; Peck CC; Rose D
    Ther Drug Monit; 1989; 11(4):455-62. PubMed ID: 2741195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of a new and simple technique for individualizing phenytoin dosage.
    Yukawa E; Higuchi S; Aoyama T
    J Pharmacobiodyn; 1989 Apr; 12(4):187-92. PubMed ID: 2795428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-point phenytoin dosage predictions in Singapore Chinese.
    Chan E
    J Clin Pharm Ther; 1997 Feb; 22(1):47-52. PubMed ID: 9292403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a Bayesian forecasting technique with a new method for estimating phenytoin dose requirements.
    Bryson SM; Al-Lanqawi Y; Kelman AW; Whiting B
    Ther Drug Monit; 1988; 10(1):80-4. PubMed ID: 3376186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Bayesian graphic method for predicting individual phenytoin dosage schedule.
    Cai WM; Chu XM; Chen G
    Zhongguo Yao Li Xue Bao; 1991 Mar; 12(2):141-4. PubMed ID: 1776478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
    Kerrick JM; Wolff DL; Graves NM
    Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenytoin dosage adjustment in Saudi epileptics: utilization of steady-state pharmacokinetic parameters.
    Abduljabbar M; Al-Khamis K; Ogunniyi A; Daif AK; Al-Yamani M
    Eur J Neurol; 1999 May; 6(3):331-4. PubMed ID: 10210914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting phenytoin dosages using Bayesian feedback: a comparison with other methods.
    Yuen GJ; Taylor JW; Ludden TM; Murphy MJ
    Ther Drug Monit; 1983; 5(4):437-41. PubMed ID: 6659016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of equations for predicting bound serum concentrations of carbamazepine and carbamazepine-10, 11-epoxide after polytherapy in patients with epilepsy.
    Kodama Y; Kuranari M; Kodama H; Tsutsumi K; Fujii I; Takeyama M
    J Clin Pharmacol; 1995 Oct; 35(10):995-1002. PubMed ID: 8568018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Michaelis-Menten kinetics and the steady-state serum phenytoin/hydroxyphenytoin ratio.
    Bourgeois BF; Wad N
    Ther Drug Monit; 1985; 7(4):405-10. PubMed ID: 4082240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
    Carlsson KC; Hoem NO; Glauser T; Vinks AA
    Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three Michaelis-Menten pharmacokinetic dosing methods compared with physician dosing of phenytoin in an outpatient neurology practice.
    Spruill WJ; Wade WE; Cobb HH; Akbari S
    Pharmacotherapy; 2001 Nov; 21(11):1407-14. PubMed ID: 11714214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenytoin dosage predictions in paediatric patients.
    Yuen GJ; Latimer PT; Littlefield LC; Mackey RW
    Clin Pharmacokinet; 1989 Apr; 16(4):254-60. PubMed ID: 2721089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivation and evaluation of an equation for prediction of free phenytoin concentration in patients co-medicated with valproic acid.
    Haidukewych D; Rodin EA; Zielinski JJ
    Ther Drug Monit; 1989; 11(2):134-9. PubMed ID: 2497562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.